全球药品契约製造市场：按服务类型、分子类型和地区划分

预计2024年全球药品契约製造市场规模将达2,113.4亿美元，2024年至2031年复合年增长率为9.70%，2031年将达4034.5亿美元。

图：按地区分類的药品契约製造市场份额（%）（2024年）

全球药品契约製造市场在过去几年中稳步成长。契约製造是指将某些製药流程（例如製造、包装和测试）外包给称为契约製造组织（CMO）的第三方公司。降低製造成本和关注核心能力的需求日益增长，是製药公司将製造需求外包给 CMO 的主要驱动力。此外，专利到期带来的持续损失、学名药需求的增加以及药物开发和商业化活动外包的增加预计将在未来几年塑造全球契约製造市场，从而进一步支持成长。

市场动态：

全球药品契约製造市场的成长是由心血管疾病盛行率上升以及世界上心律不整风险较高的老年人口不断增长所推动的。根据世界卫生组织 (WHO) 的资料，心血管疾病是全球第一大死因，每年有超过 1700 万人死于心臟病和中风。此外，专注于小型化和更长电池寿命的技术创新正在扩大心律调节器植入的适应症。然而，心律调节器手术相关的高成本以及导线缺陷和感染等装置併发症的风险可能会阻碍市场成长。

本研究的主要特点

• 该报告对全球药品契约製造市场进行了详细分析，并提供了以 2023 年为基准年的预测期（2024-2031 年）的市场规模（十亿美元）和平均年增长率（CAGR%）。
• 它还强调了各个细分市场的潜在收益成长机会，并说明了该市场有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
• 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球药品契约製造市场的主要企业。
• 主要企业包括 Lonza Group、Boehringer Ingelheim GmbH、Genpact Limited、Accenture plc、Quintiles Transnational Corporation、Baxter、Dr. Reddy's Laboratories Ltd.、Aurobindo Pharma、Pfizer, Inc.、The Almac Group、Teva Pharmaceutical Industries Ltd.、Piramal Enterprises Ltd. .、Covance, Inc.、Catalent, Inc.、Abbvie, Inc.、Celltrion 等。
• 该报告的见解将帮助负责人和公司经营团队就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
• 全球药品契约製造市场迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 透过用于分析全球药品契约製造市场的各种策略矩阵，将有助于相关人员做出决策。

目录

第一章 研究目的与前提

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章 市场动态、法规与趋势分析

• 市场动态
  • 促进因素
  • 抑制因素
  • 机会
• 影响分析
• 市场趋势
• 主要进展
• 监管场景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

第四章全球药品契约製造市场 - COVID-19 的影响

• 整体影响
• 政府倡议
• COVID-19 对市场的影响

第五章全球药品契约製造市场，依服务类型，2019-2031（十亿美元）

• Contract Manufacturing Organization (CMO)
• API Manufacturing
• Final dosage form manufacturing
• Packaging
• Contract Research Organization (CRO)
• Drug Discovery
• Preclinical Studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical Coding and Writing
• Monitoring
• Clinical Data Management
• 其他（协议开发）

第六章 全球药品契约製造市场，依分子类型，2019-2031（十亿美元）

• 低分子
• 高分子

第七章 2019-2031 年全球药品契约製造市场（按地区）（十亿美元）

第八章 竞争格局

• 公司简介
  • Lonza Group
  • Boehringer Ingelheim GmbH
  • Genpact Limited
  • Accenture plc
  • Quintiles Transnational Corporation
  • Baxter
  • Dr. Reddy's Laboratories Ltd.
  • Aurobindo Pharma
  • Pfizer, Inc.
  • The Almac Group
  • Teva Pharmaceutical Industries Ltd.
  • Piramal Enterprises Ltd.
  • Covance, Inc.
  • Catalent, Inc.
  • Abbvie, Inc.
  • Celltrion

第九章 分析师建议

第10章 参考文献与调查方法

Global contract pharmaceutical manufacturing market is estimated to be valued at USD 211.34 Bn in 2024 and is expected to reach USD 403.45 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.7% from 2024 to 2031.

Figure. Contract Pharmaceutical Manufacturing Market Share (%), By Region, 2024

The global contract pharmaceutical manufacturing market has been witnessing steady growth over the past few years. Contract pharmaceutical manufacturing refers to the outsourcing of certain pharmaceutical processes such as manufacturing, packaging, and testing of pharmaceutical drugs to a third party company known as contract manufacturing organizations (CMOs). The growing need to reduce manufacturing costs and focus on core competencies are some of the key factors driving pharmaceutical companies to outsource their production requirements to CMOs. In addition, continued patent cliff losses, rising demand for generic drugs, and increasing outsourcing of drug development and commercialization activities are further expected to support the growth of the global contract pharmaceutical manufacturing market in the coming years.

Market Dynamics:

The global contract pharmaceutical manufacturing market growth is driven by rising incidence of cardiovascular diseases and increasing elderly population base globally who are at high risk of arrhythmias. According to the data by World Health Organization, cardiovascular diseases are the leading cause of deaths worldwide with over 17 million lives lost each year due to heart attacks and strokes. Moreover, technological innovations with focus on miniaturization and battery longevity have expanded indications for pacemaker implants. However, high costs associated with pacemaker procedures and risk of device complications such as lead defects and infections can hamper the market growth.

Key Features of the Study:

• This report provides an in-depth analysis of the global contract pharmaceutical manufacturing market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global contract pharmaceutical manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes Lonza Group, Boehringer Ingelheim GmbH, Genpact Limited, Accenture plc, Quintiles Transnational Corporation, Baxter , Dr. Reddy's Laboratories Ltd., Aurobindo Pharma, Pfizer, Inc., The Almac Group, Teva Pharmaceutical Industries Ltd., Piramal Enterprises Ltd., Covance, Inc., Catalent, Inc., Abbvie, Inc., and Celltrion.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global contract pharmaceutical manufacturing market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contract pharmaceutical manufacturing market.

Detailed Segmentation-

• By Service Type:
  • Contract Manufacturing Organization (CMO)
  • API Manufacturing
  • Final dosage form manufacturing
  • Packaging
  • Contract Research Organization (CRO)
  • Drug Discovery
  • Preclinical Studies
  • Early Phase I - IIa
  • Phase IIa - III
  • Phase IIIb - IV
  • Medical Coding and Writing
  • Monitoring
  • Clinical Data Management
  • Others (Protocol Development, etc.)
• By Molecule Type:
  • Small Molecule
  • Large Molecule
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Lonza Group
  • Boehringer Ingelheim GmbH
  • Genpact Limited
  • Accenture plc
  • Quintiles Transnational Corporation
  • Baxter
  • Reddy's Laboratories Ltd.
  • Aurobindo Pharma
  • Pfizer, Inc.
  • The Almac Group
  • Teva Pharmaceutical Industries Ltd.
  • Piramal Enterprises Ltd.
  • Covance, Inc.
  • Catalent, Inc.
  • Abbvie, Inc.
  • Celltrion

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Service Type
  • Market Snapshot, By Molecule Type
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Contract Pharmaceutical Manufacturing Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Contract Pharmaceutical Manufacturing Market, By Service Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Contract Manufacturing Organization (CMO)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• API Manufacturing
• Final dosage form manufacturing
• Packaging
• Contract Research Organization (CRO)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Drug Discovery
• Preclinical Studies
• Early Phase I - IIa
• Phase IIa - III
• Phase IIIb - IV
• Medical Coding and Writing
• Monitoring
• Clinical Data Management
• Others (Protocol Development, etc.)

6. Global Contract Pharmaceutical Manufacturing Market, By Molecule Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Small Molecule
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Large Molecule
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Contract Pharmaceutical Manufacturing Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2019-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
    • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • Lonza Group
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boehringer Ingelheim GmbH
  • Genpact Limited
  • Accenture plc
  • Quintiles Transnational Corporation
  • Baxter
  • Dr. Reddy's Laboratories Ltd.
  • Aurobindo Pharma
  • Pfizer, Inc.
  • The Almac Group
  • Teva Pharmaceutical Industries Ltd.
  • Piramal Enterprises Ltd.
  • Covance, Inc.
  • Catalent, Inc.
  • Abbvie, Inc.
  • Celltrion

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact